doctor payments
Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic
While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...
Policy and public health: all the decisions we can’t see
January was a bad month for healthcare in China
Who’s calling the shots in European healthcare?
Patients versus Pharma: industry too powerful, and too cosy with EMA, says Yannis Natsis
European elections: Eurosceptics and Greens rise, but big parties hold on
Horse-trading over top jobs now begins
Europe closer to biosimilar rule change, despite fierce resistance from pharma
EFPIA says it weakens IP commitment - supporters say it will boost exports
GSK to reverse ‘no KOLs’ policy, admitting it has hit marketing
Company seeking to revive lacklustre marketing performance
Pharma sees European generics export plan as anti-innovation
EFPIA condemns plans - but European Commission says changes would create jobs in Europe
Daily Brief: Italy in turmoil, Pharma attacks Europe’s generics move and more
A rapid round up of news from pharma, biotech and healthcare
Transparency and accountability: tackling opacity and blame head-on
Let’s be honest, big pharma lacks trust and many love to hate it. Faceless corporations tainted by past own-goals, profiteering, cherry-picked data and spun claims - so goes the lazy...
Is trust in healthcare improving?
Edelman’s Annual Trust Barometer for 2017 painted a sobering picture of trust around the globe with a collapse in trust in all four of the major institutions studied - business,...
EU and UK pharma leaders appeal directly to Brexit negotiators
EFPIA, ABPI and BIA warn Michel Barnier and David Davies an unorderly withdrawal could hit medicine supplies
Europe needs ‘sustainable data ecosystem’
Better use of data must be made if patients and healthcare systems are to benefit